Promoter holding
64.27%
EO
Essity Operations Goa Limited - Due diligence report
A 360° intelligence report on Bsnmedical: trust score, financial health, credit view, compliance, directors, growth and distress signals - g…
Full Due-Diligence Report + Documents
- Unlock all financial figures & 5-year trends
- Full trust, health & credit-risk scores
- Director details, charges & MCA documents
₹700
₹349
50% off
New user
Or enjoy up to 50% off with credits
View credit packages
Company Credits – Starter
- One credit unlocks this full due-diligence report
- Use across any company’s report, anytime
- Credits valid for 12 months
Choose your own credit amount
View credit packages
Bsnmedical — 360° Intelligence Report
Generated from MCA filings & public records85/100
Trust Score
Low Risk
Bsnmedical is assessed as Low Risk with a Trust Score of 85/100. Bsnmedical is an active public limited indian non-government company incorporated in 2013, operating in the Healthcare sector. The company has shown revenue growth across its recent filed years. It was profitable in its latest filed year. Based on MCA filings and public records, it currently shows a low compliance risk and low financial risk profile.
Report generated on 09 Jul 2026 from the latest processed filings. Essity Operations Goa Limited snapshot & full profile →
Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.
02
Score Card
Higher is safer · rule-based & explainableTrust ScoreLow Risk
85/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreLow Risk
92/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreLow Risk
90/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreModerate
55/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreCaution Indicated
45/100
Board strength, DIN status, churn and network.
Growth ScoreLow Risk
85/100
Revenue, profit, asset and hiring momentum.
Distress ScoreLow Risk
90/100
Early-warning signals - higher means fewer warnings.
03
Financial Intelligence Dashboard
Standalone · 5 filed year(s)Unlock the full 5-year financial dashboard with charts and year-wise figures.
Get full accessScores and observations on this page are already computed from the real filings - only the underlying figures are locked.
04
Credit & Compliance Intelligence
Why the scores are what they are
Credit Risk Score: 55/100 Moderate
- Liabilities ≈ 38% EBITDA - stretched.
- Working-capital cover adequate.
- Profitable - internal accruals available.
Charges position: 1 open (75,000.00) · 0 satisfied (-).
Banking relationships (from registered charges)
| Lender | Charges | Amount |
|---|---|---|
| Hdfc Bank Limited | 1 | 48.0 cr |
Compliance Score: 92/100 Low Risk
- Company status is Active as per MCA.
- Annual filings current (balance sheet Mar 2025).
- Delayed payments to MSME suppliers disclosed (3 disclosure(s)).
05
Director Intelligence
Stability score: 45/100| Name | DIN / PAN | Designation | Appointed | Tenure | DIN status |
|---|---|---|---|---|---|
| YIK HING PING | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| ANIL SHYAM BHAMBHANI | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| LAWRENCE WILLIAM COLEMAN | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| NAVALBIR KUMAR | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| DALE MAXIE DE LOPES MENEZES | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| CECILIA MENEZES | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
- 6 directors on the board.
- YIK HING PING has DIN status "Deactivated due to non-filing of DIR-3 KYC".
- 3 director exit(s) in the last 3 years.
- Average tenure above 5 years.
Director & KMP remuneration (FY 2024)
| Name | Designation | Total remuneration |
|---|---|---|
| A K Sharma | Managing Director | 2.4 cr |
| R Mehta | Whole-time Director | 1.6 cr |
| S Iyer | CFO | 95.0 L |
Remuneration is disclosed in the latest annual return. Unlock full report
06
Ownership & Group Intelligence
As per FY 2025 annual returnPublic / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
Bsn Medical Netherlands Holding B.v.
Subsidiaries
-
Group entities
-
Capital events
1 allotment(s) · 0 transfer(s)
Promoters hold a dominant controlling stake - exact percentages are part of the full report.
| Group entity | Relationship | % held |
|---|---|---|
| Bsn Medical Netherlands Holding B.v. | Holding Company | 74.00% |
Full shareholding pattern, group structure & capital events →
07
Risk Intelligence Center
Growth 85 · Distress 90
Growth signals & trust indicators
Steady revenue growth: +1.42 over 4 year(s).
Profit expanded 2.1x year-on-year.
Asset base grew 24% - capacity expansion.
Net margin improved to 0.86.
EPFO headcount growing - hiring signal.
Operating for 12+ years.
Active EPFO - real payroll on record.
Distress signals & risk flags
1 open charge(s) registered - assets are encumbered.
MSME payment delays disclosed - latest outstanding 2.30 Lakh.
08
Stakeholder Verdicts
Vendor · Banker · InvestorVendor due diligence89/100
Favourable indicators
Suitability as a supplier / customer counterparty.
- Statutory record is clean.
- No distress signals on file.
- Financial filings available for verification.
Banker assessment75/100
Favourable lending indicators
Indicative lending comfort for banks, NBFCs and trade credit.
- Debt capacity assessed from filed statements.
- 1 open charge(s) of 75,000.00 already registered.
- Compliance record supports lending.
Investor view87/100
Positive growth indicators
Growth quality and scalability through an investor lens.
- 5 growth signal(s) detected.
- Margin and return trends computable from filings.
- Management churn warrants questions.
09
MCA Filings & Events Timeline
Latest 15 events24 Sep 2025
Last AGM held
Annual general meeting
31 Mar 2025
Latest balance sheet
Filed with ROC
29 Sep 2024
Director ceased
NAVALBIR KUMAR
28 Aug 2024
Director appointed
NAVALBIR KUMAR (Director)
01 Jul 2024
Director ceased
DEAN WILFRED MENEZES
29 Sep 2023
Director ceased
ANIL SHYAM BHAMBHANI
28 Sep 2022
Director appointed
ANIL SHYAM BHAMBHANI (Director)
27 Sep 2022
Director ceased
LAWRENCE WILLIAM COLEMAN
31 Aug 2022
Director ceased
NEERAJ UMASHANKAR RAGHUVANSHI
24 Nov 2021
Director appointed
LAWRENCE WILLIAM COLEMAN (Director)
17 Aug 2021
Director ceased
CARL MAGNUS DAVID STENSSON
30 Nov 2018
Director ceased
SHANKAR NARAYAN
11 Mar 2018
Director ceased
ERIK TROCK JANSEN
30 Sep 2017
Director ceased
YIK HING PING
01 Apr 2017
Director ceased
TERENCE FRANCISJUDE DSOUZA
10
Key Observations
Auto-generated from the data aboveRevenue grew 61% over the last 4 financial year(s).
Net profit margin moved from 38% to 1.42.
Debt-to-equity stands at 2.1x - leverage worth monitoring.
Net worth is positive.
Compliance record is strong - status, filings and flags are clean.
6 active director(s) / partner(s); review board churn before relying on management continuity.
EPFO-registered employer - verifiable payroll history exists.
Promoters hold a dominant controlling stake as per the FY 2025 annual return.
Director / KMP remuneration is disclosed in the latest annual return - exact figures available in the full report.
Capital has been raised through 1 security allotment(s) - amounts available in the full report.
| Company | CIN | Location |
|---|---|---|
| Paramount Surgimed | U74899DL1993PLC055981 | New Delhi, Delhi, India |
| Supreme Surfactants Private Limited | U24233DL2010PTC200617 | Azadpur, Delhi, India |
| Lewens Labs Private Limited | U24233GJ2014PTC081091 | Bharuch, Gujarat, India |
| Dhupar Chemicals Private Limited | U19116UP1986PTC008045 | Uttar Pradesh, Uttar Pradesh, India |
| Punjab Pesticides Industeries Private Limited | U24120PB2009PTC033188 | Mohali, Punjab, India |
| Sundyotanumandis | U24230GJ2011PTC067414 | Ahmedabad, Gujarat, India |
| Gorakh Nath Formulations | U24233UP2011PTC043224 | Meerut, Uttar Pradesh, India |
| Panchwati Prayogshala Private Limited | U74899UR1982PTC032733 | Roorkee, Uttarakhand, India |
12
Who Uses This Report
CA · CS · Banker · Investor · VendorChartered Accountants (CA)
Verify Bsnmedical before audits and certifications: compliance score 92/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.
Company Secretaries (CS)
Track statutory health of Bsnmedical: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.
Bankers & NBFCs
Current banker verdict: Favourable lending indicators. Credit risk score 55/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.
Investors & Analysts
Investor view: Positive growth indicators. Growth score 85/100, margin trends, ownership structure and peer set for Bsnmedical - screening before a deeper diligence.
Vendors & Procurement Teams
Vendor verdict: Favourable indicators. Trust score 85/100, distress signals and MSME payment-delay disclosures - know whether Bsnmedical pays its suppliers before you extend credit terms.
Lawyers & Compliance Teams
Litigation footprint (no cases on record), regulatory flags, charge documents trail and director networks for Bsnmedical - groundwork for KYC, onboarding and disputes.
13
Frequently Asked Questions
Is Bsnmedical an active company?
Bsnmedical has MCA status “Active” with a compliance score of 92/100 (Low Risk).
Is Bsnmedical financially healthy?
Bsnmedical has a Financial Health Score of 90/100 (Low Risk) based on its filed financial statements.
Should I do business with Bsnmedical?
Its overall Trust Score is 85/100 (Low Risk). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.
Who controls Bsnmedical?
The ultimate holding entity is Bsn Medical Netherlands Holding B.v.. 6 active director(s) are on record.
Does Bsnmedical have loans or charges against its assets?
1 open charge(s) are registered against its assets.
Is Bsnmedical up to date with its ROC filings?
Annual filings current (balance sheet Mar 2025). Overall compliance score: 92/100 (Low Risk).
Is it risky to lend to Bsnmedical?
Its Credit Risk Score is 55/100 (Moderate). Banker verdict: Favourable lending indicators.
Disclaimer: This report is generated automatically from MCA filings and public records as available
in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the
underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are
not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice.
Verify from official sources and consult a qualified professional before any business, lending or investment decision.
If you represent this company and believe any information is inaccurate or outdated,
report it here and we will review promptly.
